Screener
Vericel VCEL Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Vericel in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Vericel’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:49 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050836
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Financing activities: | ||
| Net proceeds from common stock issuance | 4,421 | 11,197 |
| Payments on employees’ behalf for taxes related to vesting of restricted stock unit awards | (4,664) | (6,343) |
| Other | (44) | (15) |
| Net cash (used in) provided by financing activities | (287) | 4,839 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 25,266 | (4,517) |
| Cash, cash equivalents, and restricted cash at beginning of period | 100,092 | 85,049 |
| Cash and cash equivalents at end of period | $125,358 | $80,532 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Vericel's cash & equivalents?
- Vericel (VCEL) reported cash & equivalents of $125.36M in Q2 2026.
- How has Vericel's cash & equivalents changed year-over-year?
- Vericel's cash & equivalents increased by 55.7% year-over-year, from $80.53M to $125.36M.
- What is the long-term trend for Vericel's cash & equivalents?
- Over 5 years (2020 to 2025), Vericel's cash & equivalents has grown at a 24.2% compound annual growth rate (CAGR), from $33.83M to $100.09M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Vericel's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude